Helsinki, Finland

Pertti Koski

USPTO Granted Patents = 11 


 

Average Co-Inventor Count = 2.9

ph-index = 4

Forward Citations = 130(Granted Patents)


Company Filing History:


Years Active: 2008-2022

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Pertti Koski: Innovator in Pharmaceutical Advances

Introduction

Pertti Koski is a distinguished inventor based in Helsinki, Finland, known for his significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 11 patents, Koski has focused on the development of modified beta-lactamases, which play a critical role in combating the adverse effects associated with beta-lactam antibiotics.

Latest Patents

Koski's most recent patent, titled "Modified Beta-Lactamases and Methods and Uses Related Thereto," represents a breakthrough in pharmaceutical sciences. This invention pertains to novel recombinant beta-lactamases and the pharmaceutical compositions that incorporate these enzymes. The patent outlines methods for modifying, producing, and utilizing beta-lactamases as medicaments, specifically aimed at preventing or treating the adverse effects caused by beta-lactam antibiotics. Additionally, the invention introduces a polynucleotide and a host cell containing this polynucleotide, providing further avenues for medical applications and research.

Career Highlights

Throughout his career, Pertti Koski has worked with organizations at the forefront of biological innovation, including Synthetic Biologics, Inc. and Ipsat Therapies Oy. His work in these reputed companies underscores his commitment to advancing pharmaceutical research and developing effective treatments.

Collaborations

Koski has collaborated with esteemed colleagues, including Ulla Airaksinen and Katja Valimaki. These partnerships highlight the collaborative nature of scientific research and innovation, allowing for the exchange of ideas and expertise that can lead to significant advancements in the field.

Conclusion

With his 11 patents and focus on innovative solutions in pharmaceuticals, Pertti Koski continues to be a key figure in the development of modified beta-lactamases. His work not only aids in enhancing the effectiveness of antibiotic treatments but also plays a vital role in addressing the challenges presented by antibiotic resistance. As he advances further in his career, Koski's contributions are sure to leave a lasting impact on the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…